Arcturus Therapeutics Holdings Inc.
ARCTArcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA (siRNA), messenger RNA (mRNA), gene editing RNA, DNA, antisense oligonucleotides, and microRNA.
Drugs in Pipeline
5
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Aug 6, 2026
TomorrowMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
ARCT Earnings Report
EPS Est: $-1.07 | FQ end 2026-06 | Call: 2026-08-06 15:00:00
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How ARCT's past catalysts played out
ARCT-2303
COVID-19
ARCT-810
OTC Deficiency
ARCT-032
Cystic Fibrosis
ARCT-165
COVID-19
ARCT-021 Dose 1
SARS-CoV-2
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ARCT-2303 | Phase 3 | COVID-19 | - | - |
ARCT-810 | Phase 2 | OTC Deficiency | - | - |
ARCT-032 | Phase 2 | Cystic Fibrosis | - | - |
ARCT-165 | Phase 2 | COVID-19 | - | - |
ARCT-021 Dose 1 | Phase 2 | SARS-CoV-2 | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Arcturus Therapeutics Holdings Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Arcturus Therapeutics Holdings Inc.'s (ARCT) pipeline across Phase 3, Phase 2. Its lead program is ARCT-2303 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Arcturus Therapeutics Holdings Inc.'s next FDA catalyst?→
Arcturus Therapeutics Holdings Inc.'s (ARCT) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ARCT biotech catalysts?→
Add ARCT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Arcturus Therapeutics Holdings Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.